Pulmonary Tuberculosis: Clinical Trials

1 trial for Pulmonary Tuberculosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow Pulmonary Tuberculosis: new trials by email Literature Review of Pulmonary Tuberculosis trials Research Report on Pulmonary Tuberculosis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis
Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS), Pretomanid, Bedaquiline, OPC-167832, and Sutezolid (PBOS), Isoniazid, Rifampicin, Pyrazinamide, Ethambutol (HRZE) - Pulmonary Tuberculosis
Phase 2TerminatedGates Medical Research Institute932023-07-262026-05-20

Narrower conditions

Tuberculosis, Multidrug-Resistant (1)  ·  Tuberculosis, Pulmonary (1)

Broader conditions

Actinomycetales Infections (1)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Gram-Positive Bacterial Infections (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Mycobacterium Infections (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)  ·  Tuberculosis (1)

Interventions

Ethambutol (1)  ·  Isoniazid (1)  ·  OPC-67683 (1)  ·  PNU-100480 (1)  ·  Pyrazinamide (1)  ·  Rifampin (1)  ·  bedaquiline (1)  ·  pretomanid (1)

Sponsors

Gates Medical Research Institute (1)

Countries

Philippines (1)  ·  South Africa (1)